NHS to restrict new weight-loss drug Mounjaro to 220,000 patients in England initially
Health officials prioritize patients with the greatest need for the "King Kong of weight-loss drugs," tirzepatide. Initial rollout over 12 years aims to protect NHS services. Only those with BMI over 35 and weight-related illness will receive the drug initially.